APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 260 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 2.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,567,700 | +28.3% | 67,500 | +207.2% | 0.09% | +23.3% |
| Q2 2023 | $2,002,014 | -66.7% | 21,976 | -75.9% | 0.07% | -70.0% |
| Q1 2023 | $6,004,009 | +62.8% | 91,025 | +68.6% | 0.24% | +38.1% |
| Q3 2022 | $3,688,000 | +79.7% | 54,000 | +33.7% | 0.18% | +87.2% |
| Q1 2022 | $2,052,000 | -9.6% | 40,377 | -15.9% | 0.09% | -24.8% |
| Q4 2021 | $2,270,000 | +292.1% | 48,013 | +255.7% | 0.12% | +557.9% |
| Q1 2021 | $579,000 | – | 13,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,160,000 | $163,403,600 | 25.44% |
| Avoro Capital Advisors LLC | 10,625,000 | $549,418,750 | 8.21% |
| Logos Global Management LP | 1,350,000 | $69,808,500 | 8.18% |
| EcoR1 Capital, LLC | 5,183,431 | $268,035,217 | 8.16% |
| Saturn V Capital Management LP | 212,329 | $9,414,319 | 7.81% |
| ACUTA CAPITAL PARTNERS, LLC | 217,500 | $11,246,925 | 6.92% |
| Ghost Tree Capital, LLC | 300,000 | $15,513,000 | 6.62% |
| Finepoint Capital LP | 334,890 | $17,317 | 5.60% |
| Cormorant Asset Management, LP | 1,576,872 | $81,540 | 5.46% |
| Tri Locum Partners LP | 221,897 | $11,474,000 | 4.64% |